☰

Suhn K. Rhie, Ph.D. - Publications

Affiliations: 
2013 Genetic, Molecular, and Cell Biology University of Southern California, Los Angeles, CA, United States 
Area:
Genetics, Molecular Biology, Bioinformatics Biology
Tree Info Similar researchers PubMed Report error

39/63 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Stevens C, Hightower A, Buxbaum SG, Falzarano SM, Rhie SK. Genomic, epigenomic, and transcriptomic signatures of prostate cancer between African American and European American patients. Frontiers in Oncology. 13: 1079037. PMID 36937425 DOI: 10.3389/fonc.2023.1079037  0.328
2023 Chen F, Madduri RK, Rodriguez AA, Darst BF, Chou A, Sheng X, Wang A, Shen J, Saunders EJ, Rhie SK, Bensen JT, Ingles SA, Kittles RA, Strom SS, Rybicki BA, et al. Evidence of Novel Susceptibility Variants for Prostate Cancer and a Multiancestry Polygenic Risk Score Associated with Aggressive Disease in Men of African Ancestry. European Urology. PMID 36872133 DOI: 10.1016/j.eururo.2023.01.022  0.318
2022 Wang X, Jordahl KM, Zhu C, Livingstone J, Rhie SK, Wright JL, Grady WM, Boutros PC, Stanford JL, Dai JY. Methylation subtypes of primary prostate cancer predict poor prognosis. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 35437583 DOI: 10.1158/1055-9965.EPI-22-0007  0.338
2021 Graff M, Justice AE, Young KL, Marouli E, Zhang X, Fine RS, Lim E, Buchanan V, Rand K, Feitosa MF, Wojczynski MK, Yanek LR, Shao Y, Rohde R, Adeyemo AA, ... ... Rhie SK, et al. Discovery and fine-mapping of height loci via high-density imputation of GWASs in individuals of African ancestry. American Journal of Human Genetics. PMID 33713608 DOI: 10.1016/j.ajhg.2021.02.011  0.302
2020 Mullen DJ, Yan C, Kang DS, Zhou B, Borok Z, Marconett CN, Farnham PJ, Offringa IA, Rhie SK. TENET 2.0: Identification of key transcriptional regulators and enhancers in lung adenocarcinoma. Plos Genetics. 16: e1009023. PMID 32925947 DOI: 10.1371/Journal.Pgen.1009023  0.337
2020 Zepeda-Martinez JA, Pribitzer C, Wang J, Bsteh D, Golumbeanu S, Zhao Q, Burkard TR, Reichholf B, Rhie SK, Jude J, Moussa HF, Zuber J, Bell O. Parallel PRC2/cPRC1 and vPRC1 pathways silence lineage-specific genes and maintain self-renewal in mouse embryonic stem cells. Science Advances. 6: eaax5692. PMID 32270030 DOI: 10.1126/Sciadv.Aax5692  0.318
2020 Xu T, Li HT, Wei J, Li M, Hsieh TC, Lu YT, Lakshminarasimhan R, Xu R, Hodara E, Morrison G, Gujar H, Rhie SK, Siegmund K, Liang G, Goldkorn A. Epigenetic plasticity potentiates a rapid cyclical shift to and from an aggressive cancer phenotype. International Journal of Cancer. PMID 32017074 DOI: 10.1002/Ijc.32904  0.404
2020 Mullen DJ, Yan C, Kang DS, Zhou B, Borok Z, Marconett CN, Farnham PJ, Offringa IA, Rhie SK. Abstract 3584: CENPA, MYBL2, and FOXM1 are identified as key transcriptional regulators in lung adenocarcinoma using TENET 2.0 Cancer Research. 80: 3584-3584. DOI: 10.1158/1538-7445.Am2020-3584  0.359
2019 Rhie SK, Perez AA, Lay FD, Schreiner S, Shi J, Polin J, Farnham PJ. A high-resolution 3D epigenomic map reveals insights into the creation of the prostate cancer transcriptome. Nature Communications. 10: 4154. PMID 31515496 DOI: 10.1038/S41467-019-12079-8  0.422
2019 Qian Y, Zhang L, Cai M, Li H, Xu H, Yang H, Zhao Z, Rhie SK, Farnham PJ, Shi J, Lu W. The prostate cancer risk variant rs55958994 regulates multiple gene expression through extreme long-range chromatin interaction to control tumor progression. Science Advances. 5: eaaw6710. PMID 31328168 DOI: 10.1126/Sciadv.Aaw6710  0.519
2019 Luo Z, Rhie SK, Farnham PJ. The Enigmatic HOX Genes: Can We Crack Their Code? Cancers. 11. PMID 30866492 DOI: 10.3390/Cancers11030323  0.348
2018 Rhie SK, Schreiner S, Witt H, Armoskus C, Lay FD, Camarena A, Spitsyna VN, Guo Y, Berman BP, Evgrafov OV, Knowles JA, Farnham PJ. Using 3D epigenomic maps of primary olfactory neuronal cells from living individuals to understand gene regulation. Science Advances. 4: eaav8550. PMID 30555922 DOI: 10.1126/Sciadv.Aav8550  0.344
2018 Wang D, Liu S, Warrell J, Won H, Shi X, Navarro FCP, Clarke D, Gu M, Emani P, Yang YT, Xu M, Gandal MJ, Lou S, Zhang J, Park JJ, ... ... Rhie SK, et al. Comprehensive functional genomic resource and integrative model for the human brain. Science (New York, N.Y.). 362. PMID 30545857 DOI: 10.1126/Science.Aat8464  0.407
2018 Guo Y, Perez AA, Hazelett DJ, Coetzee GA, Rhie SK, Farnham PJ. CRISPR-mediated deletion of prostate cancer risk-associated CTCF loop anchors identifies repressive chromatin loops. Genome Biology. 19: 160. PMID 30296942 DOI: 10.1186/S13059-018-1531-0  0.632
2018 Yang C, Stueve TR, Yan C, Rhie SK, Mullen DJ, Luo J, Zhou B, Borok Z, Marconett CN, Offringa IA. Positional integration of lung adenocarcinoma susceptibility loci with primary human alveolar epithelial cell epigenomes. Epigenomics. PMID 30212242 DOI: 10.2217/Epi-2018-0003  0.33
2018 Rhie SK, Schreiner S, Farnham PJ. Defining Regulatory Elements in the Human Genome Using Nucleosome Occupancy and Methylome Sequencing (NOMe-Seq). Methods in Molecular Biology (Clifton, N.J.). 1766: 209-229. PMID 29605855 DOI: 10.1007/978-1-4939-7768-0_12  0.346
2018 Rhie SK, Yao L, Luo Z, Witt H, Schreiner S, Guo Y, Perez AA, Farnham PJ. ZFX acts as a transcriptional activator in multiple types of human tumors by binding downstream of transcription start sites at the majority of CpG island promoters. Genome Research. PMID 29429977 DOI: 10.1101/Gr.228809.117  0.43
2017 Luo Z, Rhie SK, Lay FD, Farnham PJ. A Prostate Cancer Risk Element Functions as a Repressive Loop that Regulates HOXA13. Cell Reports. 21: 1411-1417. PMID 29117547 DOI: 10.1016/J.Celrep.2017.10.048  0.457
2017 Farshidfar F, Zheng S, Gingras MC, Newton Y, Shih J, Robertson AG, Hinoue T, Hoadley KA, Gibb EA, Roszik J, Covington KR, Wu CC, Shinbrot E, Stransky N, Hegde A, ... ... Rhie SK, et al. Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles. Cell Reports. 19: 2878-2880. PMID 28658632 DOI: 10.1016/J.Celrep.2017.06.008  0.334
2017 Huo D, Hu H, Rhie SK, Gamazon ER, Cherniack AD, Liu J, Yoshimatsu TF, Pitt JJ, Hoadley KA, Troester M, Ru Y, Lichtenberg T, Sturtz LA, Shelley CS, Benz CC, et al. Comparison of Breast Cancer Molecular Features and Survival by African and European Ancestry in The Cancer Genome Atlas. Jama Oncology. PMID 28472234 DOI: 10.1001/Jamaoncol.2017.0595  0.427
2017 Feng Y, Rhie SK, Huo D, Ruiz-Narvaez EA, Haddad SA, Ambrosone CB, John EM, Bernstein L, Zheng W, Hu JJ, Ziegler RG, Nyante S, Bandera EV, Ingles SA, Press MF, et al. Characterizing Genetic Susceptibility to Breast Cancer in Women of African Ancestry. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 28377418 DOI: 10.1158/1055-9965.Epi-16-0567  0.61
2017 Farshidfar F, Zheng S, Gingras MC, Newton Y, Shih J, Robertson AG, Hinoue T, Hoadley KA, Gibb EA, Roszik J, Covington KR, Wu CC, Shinbrot E, Stransky N, Hegde A, ... ... Rhie SK, et al. Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles. Cell Reports. 18: 2780-2794. PMID 28297679 DOI: 10.1016/J.Celrep.2017.02.033  0.347
2017 Huo D, Hu H, Rhie S, Gamazon E, Cherniack A, Liu J, Yoshimatsu T, Pitt J, Hoadley K, Troester M, Ru Y, Lichtenberg T, Sturtz L, Shelley C, Mills G, et al. Abstract P1-05-11: Comprehensive comparison of breast cancer molecular portraits by African and European ancestry in the cancer genome atlas Cancer Research. 77. DOI: 10.1158/1538-7445.Sabcs16-P1-05-11  0.451
2016 Rhie SK, Guo Y, Tak YG, Yao L, Shen H, Coetzee GA, Laird PW, Farnham PJ. Identification of activated enhancers and linked transcription factors in breast, prostate, and kidney tumors by tracing enhancer networks using epigenetic traits. Epigenetics & Chromatin. 9: 50. PMID 27833659 DOI: 10.1186/S13072-016-0102-4  0.576
2016 Yang C, Stueve TR, Marconett CN, Rhie SK, Luo J, Zhou B, Borok Z, Laird-Offringa IA. Functional lung adenocarcinoma risk SNPs identified through positional integration with human alveolar epithelial cell epigenomes Journal of Thoracic Oncology. 11: S46. DOI: 10.1016/J.Jtho.2015.12.076  0.509
2015 Ciriello G, Gatza ML, Beck AH, Wilkerson MD, Rhie SK, Pastore A, Zhang H, McLellan M, Yau C, Kandoth C, Bowlby R, Shen H, Hayat S, Fieldhouse R, Lester SC, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 163: 506-19. PMID 26451490 DOI: 10.1016/J.Cell.2015.09.033  0.412
2015 Coetzee SG, Shen HC, Hazelett DJ, Lawrenson K, Kuchenbaecker K, Tyrer J, Rhie SK, Levanon K, Karst A, Drapkin R, Ramus SJ, Couch FJ, Offit K, Chenevix-Trench G, et al. Cell-type-specific enrichment of risk-associated regulatory elements at ovarian cancer susceptibility loci. Human Molecular Genetics. 24: 3595-607. PMID 25804953 DOI: 10.1093/Hmg/Ddv101  0.696
2015 Ciriello G, Gatza ML, Hoadley KA, Zhang H, Rhie SK, Bowlby R, Wilkerson MD, Kandoth C, McLellan M, Cherniack A, Laird PW, Sander C, King TA, Perou CM. Abstract S2-04: Comprehensive molecular characterization of invasive lobular breast tumors Cancer Research. 75. DOI: 10.1158/1538-7445.Sabcs14-S2-04  0.439
2014 Rhie SK, Hazelett DJ, Coetzee SG, Yan C, Noushmehr H, Coetzee GA. Nucleosome positioning and histone modifications define relationships between regulatory elements and nearby gene expression in breast epithelial cells. Bmc Genomics. 15: 331. PMID 24885402 DOI: 10.1186/1471-2164-15-331  0.58
2014 Feng Y, Stram DO, Rhie SK, Millikan RC, Ambrosone CB, John EM, Bernstein L, Zheng W, Olshan AF, Hu JJ, Ziegler RG, Nyante S, Bandera EV, Ingles SA, Press MF, et al. A comprehensive examination of breast cancer risk loci in African American women. Human Molecular Genetics. 23: 5518-26. PMID 24852375 DOI: 10.1093/Hmg/Ddu252  0.424
2014 Hazelett DJ, Rhie SK, Gaddis M, Yan C, Lakeland DL, Coetzee SG, Henderson BE, Noushmehr H, Cozen W, Kote-Jarai Z, Eeles RA, Easton DF, Haiman CA, et al. Comprehensive functional annotation of 77 prostate cancer risk loci. Plos Genetics. 10: e1004102. PMID 24497837 DOI: 10.1371/Journal.Pgen.1004102  0.651
2013 Rhie SK, Coetzee SG, Noushmehr H, Yan C, Kim JM, Haiman CA, Coetzee GA. Comprehensive functional annotation of seventy-one breast cancer risk Loci. Plos One. 8: e63925. PMID 23717510 DOI: 10.1371/Journal.Pone.0063925  0.648
2013 Monda KL, Chen GK, Taylor KC, Palmer C, Edwards TL, Lange LA, Ng MC, Adeyemo AA, Allison MA, Bielak LF, Chen G, Graff M, Irvin MR, Rhie SK, Li G, et al. A meta-analysis identifies new loci associated with body mass index in individuals of African ancestry. Nature Genetics. 45: 690-6. PMID 23583978 DOI: 10.1038/Ng.2608  0.576
2013 Garcia-Closas M, Couch FJ, Lindstrom S, Michailidou K, Schmidt MK, Brook MN, Orr N, Rhie SK, Riboli E, Feigelson HS, Le Marchand L, Buring JE, Eccles D, Miron P, Fasching PA, et al. Genome-wide association studies identify four ER negative-specific breast cancer risk loci. Nature Genetics. 45: 392-8, 398e1-2. PMID 23535733 DOI: 10.1038/Ng.2561  0.615
2013 Chen F, Chen GK, Stram DO, Millikan RC, Ambrosone CB, John EM, Bernstein L, Zheng W, Palmer JR, Hu JJ, Rebbeck TR, Ziegler RG, Nyante S, Bandera EV, Ingles SA, ... ... Rhie SK, et al. A genome-wide association study of breast cancer in women of African ancestry. Human Genetics. 132: 39-48. PMID 22923054 DOI: 10.1007/S00439-012-1214-Y  0.497
2012 Siddiq A, Couch FJ, Chen GK, Lindström S, Eccles D, Millikan RC, Michailidou K, Stram DO, Beckmann L, Rhie SK, Ambrosone CB, Aittomäki K, Amiano P, Apicella C, et al. A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11. Human Molecular Genetics. 21: 5373-84. PMID 22976474 DOI: 10.1093/Hmg/Dds381  0.614
2012 Coetzee SG, Rhie SK, Berman BP, Coetzee GA, Noushmehr H. FunciSNP: an R/bioconductor tool integrating functional non-coding data sets with genetic association studies to identify candidate regulatory SNPs. Nucleic Acids Research. 40: e139. PMID 22684628 DOI: 10.1093/Nar/Gks542  0.616
2012 Noushmehr H, Coetzee SG, Rhie SK, Yan C, Haiman CA, Berman BP, Frenkel B, Coetzee GA. Abstract 1646: Integrative analysis identifies functional prostate cancer risk SNPs in genomic regulatory regions defined as enhancers Cancer Research. 72: 1646-1646. DOI: 10.1158/1538-7445.Am2012-1646  0.662
2012 Noushmehr H, Coetzee SG, Rhie SK, Yan C, Coetzee GA. The functionality of prostate cancer predisposition risk regions is revealed by AR enhancers Androgen-Responsive Genes in Prostate Cancer: Regulation, Function and Clinical Applications. 59-84. DOI: 10.1007/978-1-4614-6182-1_5  0.626
Low-probability matches (unlikely to be authored by this person)
2021 Baban Ghate N, Kim S, Spiller E, Kim S, Shin Y, Rhie SK, Smbatyan G, Lenz HJ, Mumenthaler SM, An W. VprBP directs epigenetic gene silencing through histone H2A phosphorylation in colon cancer. Molecular Oncology. PMID 34312968 DOI: 10.1002/1878-0261.13068  0.293
2019 O'Geen H, Bates SL, Carter SS, Nisson KA, Halmai J, Fink KD, Rhie SK, Farnham PJ, Segal DJ. Ezh2-dCas9 and KRAB-dCas9 enable engineering of epigenetic memory in a context-dependent manner. Epigenetics & Chromatin. 12: 26. PMID 31053162 DOI: 10.1186/S13072-019-0275-8  0.275
2021 Polfus LM, Darst BF, Highland H, Sheng X, Ng MCY, Below JE, Petty L, Bien S, Sim X, Wang W, Fontanillas P, Patel Y, ... ... Rhie SK, et al. Genetic discovery and risk characterization in type 2 diabetes across diverse populations. Hgg Advances. 2. PMID 34604815 DOI: 10.1016/j.xhgg.2021.100029  0.271
2023 Ghate NB, Kim S, Shin Y, Kim J, Doche M, Valena S, Situ A, Kim S, Rhie SK, Lenz HJ, Ulmer TS, Mumenthaler SM, An W. Phosphorylation and stabilization of EZH2 by DCAF1/VprBP trigger aberrant gene silencing in colon cancer. Nature Communications. 14: 2140. PMID 37069142 DOI: 10.1038/s41467-023-37883-1  0.266
2020 Ashton C, Rhie SK, Carmichael JD, Zada G. Role of KCNAB2 expression in modulating hormone secretion in somatotroph pituitary adenoma. Journal of Neurosurgery. 1-7. PMID 32109873 DOI: 10.3171/2019.12.Jns192435  0.237
2023 Hodara E, Mades A, Swartz L, Iqbal M, Xu T, Bsteh D, Farnham PJ, Rhie SK, Goldkorn A. mA epitranscriptome analysis reveals differentially methylated transcripts that drive early chemoresistance in bladder cancer. Nar Cancer. 5: zcad054. PMID 38023731 DOI: 10.1093/narcan/zcad054  0.232
2021 Lee BH, Rhie SK. Molecular and computational approaches to map regulatory elements in 3D chromatin structure. Epigenetics & Chromatin. 14: 14. PMID 33741028 DOI: 10.1186/s13072-021-00390-y  0.227
2022 Lu YT, Xu T, Iqbal M, Hsieh TC, Luo Z, Liang G, Farnham PJ, Rhie SK, Goldkorn A. FOXC1 Binds Enhancers and Promotes Cisplatin Resistance in Bladder Cancer. Cancers. 14. PMID 35406487 DOI: 10.3390/cancers14071717  0.227
2020 Liu D, Cen S, Liang G, Siegmund K, Varghese B, Rhie S, Lei X, Hajian S, Aron M, Zahoor H, hwang D, Desai M, Gill I, Duddalwar* V. MP18-20 DEVELOPING A RADIOMIC SIGNATURE TO EVALUATE THE RAS-MAPK PATHWAY IN CLEAR CELL RENAL CELL CARCINOMA The Journal of Urology. 203: e243. DOI: 10.1097/Ju.0000000000000843.020  0.224
2009 Peter AK, Ko CY, Kim MH, Hsu N, Ouchi N, Rhie S, Izumiya Y, Zeng L, Walsh K, Crosbie RH. Myogenic Akt signaling upregulates the utrophin-glycoprotein complex and promotes sarcolemma stability in muscular dystrophy. Human Molecular Genetics. 18: 318-27. PMID 18986978 DOI: 10.1093/Hmg/Ddn358  0.219
2020 Duddalwar* V, Zahoor H, Siddiqui I, Aron M, Varghese B, Fullenkamp A, Cen S, Sali A, DʼSouza A, Rhie S, Lei X, Rivas M, Liu D, Hwang D, Quinn D, et al. PD39-04 PREDICTING CD8+ T CELL INFILTRATION AND PD-L1 EXPRESSION IN RENAL CELL CARCINOMA USING CT RADIOMIC SIGNATURES The Journal of Urology. 203: e809-e810. DOI: 10.1097/Ju.0000000000000918.04  0.205
2022 Lee Y, Wu Z, Yang S, Schreiner SM, Gonzalez-Smith LD, Rhie SK. Characterizing and Targeting Genes Regulated by Transcription Factor MYBL2 in Lung Adenocarcinoma Cells. Cancers. 14. PMID 36291764 DOI: 10.3390/cancers14204979  0.195
2021 Shin Y, Kim S, Ghate NB, Rhie SK, An W. MMP-9 drives the melanomagenic transcription program through histone H3 tail proteolysis. Oncogene. PMID 34785776 DOI: 10.1038/s41388-021-02109-5  0.182
2023 Lu YT, Plets M, Morrison G, Cunha AT, Cen SY, Rhie SK, Siegmund KD, Daneshmand S, Quinn DI, Meeks JJ, Lerner SP, Petrylak DP, McConkey D, Flaig TW, Thompson IM, et al. Cell-free DNA Methylation as a Predictive Biomarker of Response to Neoadjuvant Chemotherapy for Patients with Muscle-invasive Bladder Cancer in SWOG S1314. European Urology Oncology. PMID 37087309 DOI: 10.1016/j.euo.2023.03.008  0.169
2023 Tucker DW, Pangal DJ, Du R, Gogia AS, Tafreshi A, Ruzevick J, Hurth KT, Triche T, Micko A, Carpten JD, Shiroishi MS, Carmichael JD, Rhie SK, Zada G. Validation of Myc-Associated Protein X (MAX) regulation in growth hormone secreting and nonfunctional pituitary adenoma. Plos One. 18: e0284949. PMID 37104368 DOI: 10.1371/journal.pone.0284949  0.166
2022 Lee BH, Wu Z, Rhie SK. Characterizing chromatin interactions of regulatory elements and nucleosome positions, using Hi-C, Micro-C, and promoter capture Micro-C. Epigenetics & Chromatin. 15: 41. PMID 36544209 DOI: 10.1186/s13072-022-00473-4  0.148
2023 Reams RR, Odedina FT, Carpten JD, Redda K, Stern MC, Krieger JL, Aparicio J, Hensel B, Askins N, Abreu A, Adams A, Agyare E, Ali J, Allen JM, Aló R, ... ... Rhie SK, et al. Florida-California Cancer Research, Education and Engagement (CaRE) Health Equity Center: Structure, Innovations, and Initial Outcomes. Cancer Control : Journal of the Moffitt Cancer Center. 30: 10732748231197878. PMID 37703814 DOI: 10.1177/10732748231197878  0.142
2023 Lee BH, Wu Z, Rhie SK. Correction: Characterizing chromatin interactions of regulatory elements and nucleosome positions, using Hi‑C, Micro‑C, and promoter capture Micro‑C. Epigenetics & Chromatin. 16: 22. PMID 37286980 DOI: 10.1186/s13072-023-00498-3  0.132
2023 Liu D, Dani K, Reddy SS, Lei X, Demirjian N, Hwang D, Varghese BA, Rhie SK, Yap FY, Quinn DI, Siddiqi I, Aron M, Vaishampayan U, Zahoor H, Cen SY, et al. Radiogenomic associations clear cell renal cell carcinoma: an exploratory study. Oncology. PMID 37080171 DOI: 10.1159/000530719  0.125
2022 Wedemeyer MA, Muskens I, Strickland BA, Aurelio O, Martirosian V, Wiemels JL, Weisenberger DJ, Wang K, Mukerjee D, Rhie SK, Zada G. Epigenetic dysregulation in meningiomas. Neuro-Oncology Advances. 4: vdac084. PMID 35769412 DOI: 10.1093/noajnl/vdac084  0.108
2022 Varghese B, Cen S, Zahoor H, Siddiqui I, Aron M, Sali A, Rhie S, Lei X, Rivas M, Liu D, Hwang D, Quinn D, Desai M, Vaishampayan U, Gill I, et al. Feasibility of using CT radiomic signatures for predicting CD8-T cell infiltration and PD-L1 expression in renal cell carcinoma. European Journal of Radiology Open. 9: 100440. PMID 36090617 DOI: 10.1016/j.ejro.2022.100440  0.089
2021 Demirjian NL, Varghese BA, Cen SY, Hwang DH, Aron M, Siddiqui I, Fields BKK, Lei X, Yap FY, Rivas M, Reddy SS, Zahoor H, Liu DH, Desai M, Rhie SK, et al. CT-based radiomics stratification of tumor grade and TNM stage of clear cell renal cell carcinoma. European Radiology. PMID 34757449 DOI: 10.1007/s00330-021-08344-4  0.068
2011 Rhie SK, Lee SH, Chae KY. Sleep patterns and school performance of Korean adolescents assessed using a Korean version of the pediatric daytime sleepiness scale Korean Journal of Pediatrics. 54: 29-35. DOI: 10.3345/kjp.2011.54.1.29  0.02
2013 Kang JW, Rhie SK, Yu R, Eom S, Hong W, Kim SH, Kang HC, Lee JS, Lee YM, Kim HD. Seizure outcome of infantile spasms with focal cortical dysplasia. Brain & Development. 35: 816-20. PMID 23871103 DOI: 10.1016/j.braindev.2013.06.013  0.019
Hide low-probability matches.